This is a routine inducement grant with negligible dilution. No trading signal, monitor upcoming clinical catalysts for azenosertib (WEE1 inhibitor) in ovarian cancer for material moves.
ZNTL drugs
ZNTL drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 2 $3.95entry
- T+1 · 6mo ago −5.82%α −5.10% · $3.72
- T+5 · 5mo ago −9.37%α −6.40% · $3.58
- T+20 · 5mo ago +10.25%α +11.82% · $4.36
- T+60 · 3mo ago −1.52%α −2.64% · $3.89
Price Chart
How similar events traded
Executive Summary
Zentalis granted 191,000 non-qualified stock options to two newly hired employees as an inducement for employment, with a $3.98 exercise price and four-year vesting. This is a routine equity inducement grant with no material financial impact.
Key Facts
- 191,000 stock options granted to two new employees under the 2022 Inducement Plan
- Exercise price of $3.98 per share, equal to the closing price on the grant date
- Options vest over four years: 25% at first anniversary, then monthly over three years
- Grant is an inducement material to employment per Nasdaq Listing Rule 5635(c)(4)
Financial Impact
191,000 options at $3.98 strike; dilution is immaterial relative to ~50M shares outstanding (est. <0.4%)
Risk Factors
- No clinical or financial data disclosed; stock moves on pipeline events, not this grant
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3304753 |
Track record
18 reports on ZNTL
5 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +51.42% at T+60 after the Aug 14, 2026 report. 6 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 4/10 Entry $1.62 Now $1.60 −1.23% settles Feb 12
- Nov 9, 20267d ago 8-K Bearish 5/10 Entry $1.80 Now $1.60 +11.11% settles Feb 8
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $2.06 Now $1.60 −22.33% settles Jan 26
- Oct 18, 202629d ago Press Release Bullish 7/10 Entry $2.30 Now $1.60 −30.43% settles Jan 14
- Oct 1, 20266w ago Press Release Neutral 2/10 Entry $2.52 Now $1.60 −36.51% settles Dec 29
- Aug 14, 202613w ago 8-K Bearish 6/10 Entry $3.71 to $1.80 Now $1.60 +56.82% ▲ +51.42% +48.47% vs SPY
- Aug 13, 202613w ago Press Release Bearish 6/10 Entry $3.56 to $1.74 Now $1.60 +55.06% ▲ +51.12% +48.08% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $3.75 to $4.03 Now $1.60 −57.33% ▲ +7.47% +4.20% vs SPY
- Jun 1, 202624w ago Press Release Neutral 2/10 Viewing Entry $3.95 to $3.89 Now $1.60 −59.49% ▼ −1.52% −2.64% vs SPY
- May 21, 202625w ago Press Release Bullish 6/10 Entry $4.06 to $3.68 Now $1.60 −60.59% ▼ −9.36% −12.55% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers